PAPER Ninan I, Bath KG, Dagar K, Perez-Castro R, Plummer MR, Lee FS, Chao MV
SEARCH RESULTS
331159 RESULTS
PAPER Smith TH, Sim-Selley LJ, Selley DE
Cannabinoid CB1 receptor-interacting proteins: novel targets for central nervous system drug discovery?
Br J Pharmacol. 2010 Jun;160(3):454-66. PubMed: 20590557PAPER Scotter EL, Abood ME, Glass M
The endocannabinoid system as a target for the treatment of neurodegenerative disease.
Br J Pharmacol. 2010 Jun;160(3):480-98. PubMed: 20590559PAPER Dubois-Dauphin ML, Toni N, Julien SD, Charvet I, Sundstrom LE, Stoppini L
The long-term survival of in vitro engineered nervous tissue derived from the specific neural differentiation of mouse embryonic stem cells.
Biomaterials. 2010 Sep;31(27):7032-42. PubMed: 20591476PAPER Chiocco MJ, Zhu X, Walther D, Pletnikova O, Troncoso JC, Uhl GR, Liu QR
Fine mapping of calcineurin (PPP3CA) gene reveals novel alternative splicing patterns, association of 5'UTR trinucleotide repeat with addiction vulnerability, and differential isoform expression in Alzheimer's disease.
Subst Use Misuse. 2010 Sep;45(11):1809-26. PubMed: 20590401PAPER Mozer AB, Whittemore SR, Benton RL
Spinal microvascular expression of PV-1 is associated with inflammation, perivascular astrocyte loss, and diminished EC glucose transport potential in acute SCI.
Curr Neurovasc Res. 2010 Aug;7(3):238-50. PubMed: 20590523PAPER Popa-Wagner A, Pirici D, Petcu EB, Mogoanta L, Buga AM, Rosen CL, Leon R, Huber J
Pathophysiology of the vascular wall and its relevance for cerebrovascular disorders in aged rodents.
Curr Neurovasc Res. 2010 Aug;7(3):251-67. PubMed: 20590524PAPER Bloch MJ, Basile JN
Angiotensin receptor blocker use may decrease the incidence and progression of Alzheimer's disease and dementia in older men but the strength of the evidence is questionable.
J Clin Hypertens (Greenwich). 2010 Jun;12(6):444-6. PubMed: 20591090PAPER Ethell DW
An amyloid-notch hypothesis for Alzheimer's disease.
Neuroscientist. 2010 Dec;16(6):614-7. PubMed: 20592273PAPER Schoder D, Hannequin D, Martinaud O, Opolczynski G, Guyant-Maréchal L, Le Ber I, Campion D
Morbid risk for schizophrenia in first-degree relatives of people with frontotemporal dementia.
Br J Psychiatry. 2010 Jul;197(1):28-35. PubMed: 20592430PAPER Lin K, Tang M, Han H, Guo Y, Lin Y, Ma C
Association between the polymorphisms of CALHM1 and GOLPH2 genes and Alzheimer's disease.
Psychiatr Genet. 2010 Aug;20(4):190. PubMed: 20592574PAPER Benedetti F, Carlino E, Pollo A
How placebos change the patient's brain.
Neuropsychopharmacology. 2011 Jan;36(1):339-54. PubMed: 20592717PAPER Hampel H, Frank R, Broich K, Teipel SJ, Katz RG, Hardy J, Herholz K, Bokde AL, Jessen F, Hoessler YC, Sanhai WR, Zetterberg H, Woodcock J, Blennow K
Biomarkers for Alzheimer's disease: academic, industry and regulatory perspectives.
Nat Rev Drug Discov. 2010 Jul;9(7):560-74. PubMed: 20592748PAPER Ahn HJ, Chin J, Park A, Lee BH, Suh MK, Seo SW, Na DL
Seoul Neuropsychological Screening Battery-dementia version (SNSB-D): a useful tool for assessing and monitoring cognitive impairments in dementia patients.
J Korean Med Sci. 2010 Jul;25(7):1071-6. PubMed: 20592901PAPER Bockhorn JJ, Lazar KL, Gasser AJ, Luther LM, Qahwash IM, Chopra N, Meredith SC
Novel semisynthetic method for generating full length beta-amyloid peptides.
Biopolymers. 2010;94(4):511-20. PubMed: 20593467Current Filters
No filters selected